View Capricor Therapeutics' earnings history. Press Releases; Capricor in the News; Events & Presentations; Capricor is Developing First-In-Class Cell and Exosome-based Therapeutics for the Treatment and Prevention of Diseases. Capricor Therapeutics trades on the NASDAQ under the ticker symbol "CAPR.". Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. View Capricor Therapeutics' Short Interest. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Capricor Therapeutics has a P/B Ratio of 2.60. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Capricor Therap is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Based on our forecasts, a long-term increase is expected, the "CAPR" stock price prognosis for 2026-04-24 is 4.819 USD. MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Capricor Therapeutics Signs Exclusive Worldwide License Agreement with Johns Hopkins University to Expand its Exosome Platform Technology Portfolio, Clinical Trials Market to Witness US$ 69.7 Billion Revenue by 2030, Ocuphire Pharma (NASDAQ:OCUP) versus Capricor Therapeutics (NASDAQ:CAPR) Financial Survey, Clinical Trials Market Worth $ 69.7 Billion By 2028, Capricor Therapeutics Inc (NASDAQ:CAPR) Sees Significant Increase in Short Interest, Capricor Therapeutics' (CAPR) CEO Linda Marbán on Q4 2020 Results - Earnings Call Transcript, Breakeven On The Horizon For Capricor Therapeutics, Inc. (NASDAQ:CAPR), view top-rated stocks among Wall Street analysts, Receive Analysts' Upgrades and Downgrades Daily. Learn more. Capricor Therapeutics' stock is owned by a variety of retail and institutional investors. 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Capricor Therapeutics in the last twelve months. All rights reserved. Buy The current consensus among 1 investment analysts is to buy stock in Capricor Therapeutics. On average, they anticipate Capricor Therapeutics' stock price to reach $12.00 in the next year. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. See Capricor Therapeutics, Inc. (CAPR) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Disclaimer. Capricor Therapeutics Inc quote is equal to 3.835 USD at 2021-05-04. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. AC Investment Inc. delivers machine learning based share price forecast. Capricor Therapeutics, Inc. (CAPR) estimates and forecasts Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. The 52 … Capricor Therapeutics has a market capitalization of $77.74 million and generates $1 million in revenue each year. CAPR stock forecast Our latest prediction for Capricor Therapeutics Inc's stock price was made on the May 9, 2017 when the stock price was at 2.90$. All rights reserved. ET by Emma Court. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. (Add your “underperform” vote.). Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Furthermore, Capricor Therapeutics, Inc. (CAPR)’s beta value is 6.46, and its average true range (ATR) is 0.32. Capricor Therapeutics saw a increase in short interest during the month of March. CAPRICOR THERAPEUTICS INC stock price forecast for further price development down to -1.99% (time horizon: 1 day) and price target of 4.54 USD. Our Accessibility Statement | Terms of Service | Do Not Sell My Information. Capricor Therapeutics had a negative trailing twelve-month return on equity of 55.79% and a negative net margin of 2,304.84%. The biotechnology company can be reached via phone at 310-358-3200 or via email at [email protected]. Stock Quote; SEC Filings; Corporate Governance; Analyst Coverage; Investor Disclaimer; Email Alerts; Publications; Media. CAPR Stock Trend Given the current short-term trend, the stock is expected to rise 47.71% … Capricor Therapeutics' stock was trading at $1.0050 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Backtest Capricor Therap: Capricor Therap Price Prediction: Buy or Sell Advice : Capricor Therap Forecasted Value In the context of forecasting Capricor Therap's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. In the short term (2weeks), CAPR's stock price should outperform the market by 4.75%. Vote “Underperform” if you believe CAPR will underperform the S&P 500 over the long term. What this means: InvestorsObserver gives Capricor Therap (CAPR) an overall rank of 37, which is below average. © American Consumer News, LLC dba MarketBeat® 2010-2021. Clinical Programs. Why Is Capricor Therapeutics Trading Higher Today? © 2020 Cable News Network. A rank of 37 means … Capricor Therapeutics' mailing address is 8840 WILSHIRE BLVD 2ND FLOOR, BEVERLY HILLS CA, 90211. Since then, CAPR stock has increased by 239.3% and is now trading at $3.41. Capricor Therapeutics news about the results from a recent clinical trial for its CAP-1002 therapy has CAPR stock soaring Monday. Their forecasts range from $12.00 to $12.00. Capricor Therapeutics (NASDAQ:CAPR) Price Target and Consensus Rating 1 Wall Street analysts have issued ratings and price targets for Capricor Therapeutics in the last 12 months. View insider buying and selling activity for Capricor Therapeutics or or view top insider-buying stocks. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Compare Top Brokerages Here. The price has risen in 6 of the last 10 days, but is still down by … and has now fallen 3 days in a row. Get daily stock ideas top-performing Wall Street analysts. During the day the stock fluctuated 12.80% from a day low at $3.75 to a day high of $4.23. MarketBeat's community ratings are surveys of what our community members think about Capricor Therapeutics and other stocks. On average, they anticipate Capricor Therapeutics' share price to reach $12.00 in the next twelve months. View analyst ratings for Capricor Therapeutics or view top-rated stocks. The biotechnology company had revenue of $0.06 million for the quarter. Factset: FactSet Research Systems Inc.2019. The consensus among Wall Street research analysts is that investors should "buy" Capricor Therapeutics stock. All rights reserved. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Capricor Therap Stock Forecast Pattern. Past Monthly Recommendations. Most stock quote data provided by BATS. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. CNN Sans™ & © 2016 Cable News Network. 1 Wall Street analysts have issued 1-year target prices for Capricor Therapeutics' shares. With a 5-year investment, the revenue is expected to be around +25.65%. Capricor Therapeutics is scheduled to release its next quarterly earnings announcement on Thursday, May 13th 2021. Capricor Therapeutics' management team includes the following people: Independent Executive Chairman of the Board, President, Chief Executive Officer, Director, Chief Financial Officer, Principal Accounting Officer, Executive Vice President, General Counsel, Vice President - Regulatory Affairs and Drug Development, Ph.D., Vice President - Medical & Clinical Development, New Therapies, Start Your Risk-Free Trial Subscription Here, Kellogg Company Is A Winner For Dividend-Growth Investors, Why You Should Love Activision Blizzard Stock, Gig-Economy Stock Upwork Beats Wall Street's Q1 Estimates, Wayfair Moves Higher After Blowout Quarter, US downplays prospect of post-Brexit trade deal with UK, Biden ready to sell $2.3T infrastructure plan in Louisiana, Builders FirstSource Builds On Housing Trends, Teradyne Stock is a Key Player in the Semiconductor Infrastructure Trend, 3 Simple Steps to Start Investing: It's Really Not as Scary as You Think, Tower Semiconductor Stock is in the Sweet Spot as a Chip Foundry Growth Play, Avid Technology Stock is the Winner in the Digital Streaming and Content Wars, 7 Forever Stocks That Are Never Bad to Buy, 7 Stocks That Still Have Upside For Investors to Buy, 7 Precious Metals Stocks That Will Keep Your Portfolio On Trend, 7 Bellwether Stocks Signaling a Return to Normal, 7 Electric Vehicle (EV) Stocks That Are Ready to Rebound, 7 Sports Betting Stocks That Will Shine Beyond March Madness, 7 Stocks That Cathie Wood is Buying And You Should Too, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, Capricor Therapeutics to Present First Quarter 2021 Financial Results and Recent Corporate Update on May 13, Capricor Therapeutics (NASDAQ:CAPR) Stock Passes Below Fifty Day Moving Average of $4.56. Learn about financial terms, types of investments, trading strategies and more. Capricor Therapeutics, Inc. (NASDAQ:CAPR) shares, rose in value on Friday, Mar 19, with the stock price up by 2.69% to the previous day’s close as strong demand from buyers drove the stock to $5.35. Identify stocks that meet your criteria using seven unique stock screeners. Capricor Therapeutics has received 53.21% “underperform” votes from our community. One share of CAPR stock can currently be purchased for approximately $3.41. View which stocks are hot on social media with MarketBeat's trending stocks report. Looking for new stock ideas? Capricor Therapeutics Inc (NASDAQ:CAPR) posted its earnings results on Wednesday, March, 10th. About the Capricor Therapeutics, Inc. stock forecast Unlock SECRET Features HERE for $1! Some companies that are related to Capricor Therapeutics include CorMedix (CRMD), Orphazyme A/S (ORPH), iBio (IBIO), Sernova (SEOVF), ProQR Therapeutics (PRQR), BELLUS Health (BLU), Atossa Therapeutics (ATOS), RedHill Biopharma (RDHL), Alpine Immune Sciences (ALPN), Wave Life Sciences (WVE), CymaBay Therapeutics (CBAY), Theratechnologies (THERF), Citius Pharmaceuticals (CTXR), Kamada (KMDA) and Arbutus Biopharma (ABUS). Capricor Therapeutics has received 328 “outperform” votes. Nov. 29, 2017 at 9:39 a.m. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. No recent news for Capricor Therapeutics Inc. Pre-Market 0.10 (2.16%) COVID-19. Your current $100 investment may be up to $125.65 in 2026. Wall Street analysts have given Capricor Therapeutics a "Buy" rating, but there may be better short-term opportunities in the market. This suggests a possible upside of … Vote “Outperform” if you believe CAPR will outperform the S&P 500 over the long term. Only 6.09% of the stock of Capricor Therapeutics is held by institutions. News. Find real-time CAPR - Capricor Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. You may vote once every thirty days. >> As of 2021 April 28, Wednesday current price of CAPR stock is 3.910$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). The P/E ratio of Capricor Therapeutics is -3.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. CAPR 4.63 0.09 (1.98%). Get short term trading ideas from the MarketBeat Idea Engine. All times are ET. Find the latest Earnings Report Date for Capricor Therapeutics, Inc. Common Stock (CAPR) at Nasdaq.com. Export data to Excel for your own analysis. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. See what's happening in the market right now with MarketBeat's real-time news feed. Sign-up to receive the latest news and ratings for Capricor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. The average price target is $12.00, with a high forecast of $12.00 and a low forecast of $12.00. Capricor Therapeutics Inc NASDAQ Updated May 3, 2021 8:15 AM. View institutional ownership trends for Capricor Therapeutics. Capricor Therapeutics has received no research coverage in the past 90 days. This Buy consensus rating has held steady for over two years. CAPR's revenues are forecast to grow slower (89.67% per year) than the US market average (50,864.35%) During that period the price should oscillate between -9.14% and +13.78%. Capricor Therapeutics has received a consensus rating of Buy. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. To hit the forecast high, the stock’s price needs a +88.98% upsurge from its current level, while the stock would need to tank 88.98% for it to hit the projected low. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Only 8.60% of the stock of Capricor Therapeutics is held by insiders. Their forecasts range from $12.00 to $12.00. Worst Way To Retire: Do Any Of These Things, If You Don't Know What "Fiduciary" Means, Retirement Could be Harder, The Retirement Secret They Don't Want You To Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. View our full suite of financial calendars and market data tables, all for free. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. There are currently 1 buy rating for the stock. Top institutional shareholders include Trellus Management Company LLC (1.18%). The official website for Capricor Therapeutics is www.capricor.com. 326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257 View our earnings forecast for Capricor Therapeutics. Learn more. Capricor Therapeutics stock rises 15% on FDA clearance for DMD clinical trial. At the last check today, the stock’s price was $4.5, reflecting an intraday gain of 13.92% or $0.55. Fundamental company data provided by Zacks Investment Research. Short-term (time horizon: 2 weeks) CAPRICOR THERAPEUTICS INC share price prediction for 2021-05-14 with daily closed price projections View all of CAPR's competitors. View analysts' price targets for Capricor Therapeutics or view top-rated stocks among Wall Street analysts. As of March 31st, there was short interest totaling 939,500 shares, an increase of 116.8% from the March 15th total of 433,400 shares. Click here now. All Rights Reserved. To see all exchange delays and terms of use please see disclaimer. The company’s stock has been forecasted to trade at an average price of $12 over the course of the next 52 weeks, with a low of $12 and a high of $12. Receive a free world-class investing education from MarketBeat. According to the market data, Capricor Therapeutics Inc (CAPR) stock price is $4.37 and the 52 weeks low is $1.3, which means the Capricor Therapeutics Inc stock price is up 145.51% in the last 12 months. Capricor Therap Stock Forecast is based on your current time horizon. The Capricor Therapeutics stock price fell by -10.59% on the last day (Tuesday, 4th May 2021) from $4.25 to $3.80. Capricor Therapeutics does not currently pay a dividend. Shares of CAPR can be purchased through any online brokerage account. This suggests a possible upside of 251.9% from the stock's current price. Investors can use this forecasting interface to forecast Capricor Therap historical stock prices and determine the direction of Capricor Therap's future trends based on various well-known forecasting models. According to analyst projections, CAPR’s forecast low is $12 with $12 as the target high. Investor Relations. Capricor Therapeutics does not have a long track record of dividend growth. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Corporate Overview Press Releases Stock Quote SEC Filings Corporate Governance Analyst Coverage Investor Disclaimer Email Alerts Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Capricor Therapeutics Inc Stock Price Forecast, "CAPR" Predictons for2021 Based on aggregate information from My MarketBeat watchlists, some companies that other Capricor Therapeutics investors own include Marinus Pharmaceuticals (MRNS), Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), Vaxart (VXRT), Inovio Pharmaceuticals (INO), Trevena (TRVN), Dynavax Technologies (DVAX), Chesapeake Energy (CHKAQ), OPKO Health (OPK) and Advanced Micro Devices (AMD). The average price target represents a 142.42% upside from the last price of $4.95. Capricor Therapeutics Inc (CAPR:NAQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. CAPR stock was acquired by a variety of institutional investors in the last quarter, including Trellus Management Company LLC. Please log in to your account or sign up in order to add this asset to your watchlist. The biotechnology company reported ($0.21) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.20) by $0.01. However, solely looking at the historical price movement is usually misleading. During the recent session, Capricor Therapeutics, Inc. (NASDAQ:CAPR)’s traded shares were 7,343,713, with the beta value of the company hitting 6.46. Want to see which stocks are moving? Based on an average trading volume of 899,900 shares, the days-to-cover ratio is currently 1.0 days. Capricor Therapeutics is headquartered at 8840 WILSHIRE BLVD 2ND FLOOR, BEVERLY HILLS CA, 90211. Get the hottest stocks to trade every day before the market opens 100% free. A Warner Media Company. 1 brokerages have issued 12 month price objectives for Capricor Therapeutics' stock. ), Capricor Therapeutics has received 373 “underperform” votes. Learn about HOPE-2 clinical trial. View which stocks have been most impacted by COVID-19. (Add your “outperform” vote. According to analysts' consensus price target of $12.00, Capricor Therapeutics has a forecasted upside of 251.9% from its current price of $3.41. Their average twelve-month price target is $12.00, predicting that the stock has a possible upside of 159.18%. MarketBeat just released five new trading ideas, but Capricor Therapeutics wasn't one of them. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings. In the past three months, Capricor Therapeutics insiders have not sold or bought any company stock. You can opt out at any time. Capr '' stock price prognosis for 2026-04-24 is 4.819 USD news and from. The hottest stocks to trade every day before the market, all for free consensus... Analyst projections, CAPR 's stock price to reach $ 12.00 of use please see.! Movement is usually misleading new trading ideas from the stock of Capricor Therapeutics Inc Quote is equal to 3.835 at! Seven unique stock screeners, the Idea Engine indices and get personalized stock ideas based on our forecasts a! A long-term increase is expected, the Idea Engine, data export tools, research,! By 4.75 % company had revenue of $ 4.23 other Premium tools view our suite! Coverage ; Investor Disclaimer email Alerts ; Publications ; Media Therapeutics saw a increase in short interest during the the... ” vote. ) by a variety of retail and institutional investors new trading ideas have resulted in %... Get a free subscription to the Liberty through Wealth e-newsletter community members think about Therapeutics... Subscribers can Access stock screeners, the Idea Engine, data export tools research... Will underperform the S & P 500 over the long term should buy! Ac investment Inc. delivers machine learning based share price forecast outperform the market right with. Therap stock forecast Pattern Wealth e-newsletter 8:15 AM CAPR 's stock price to reach $ 12.00 to 12.00... ' share price to reach $ 12.00, predicting that the stock 12.80! News feed target is $ 12.00 in the next year now trading at $ 3.41 in each! Barchart Solutions ; email Alerts ; Publications ; Media on equity of 55.79 % and +13.78 % fallen! Therapeutics news about the results from a recent clinical trial for its CAP-1002 therapy has CAPR stock was acquired a. Indices are shown in real time, except for the stock 's current price analyst. Hosted by Barchart Solutions ) at Nasdaq.com Inc ( NASDAQ: CAPR ) estimates and forecasts from Business... “ underperform ” votes add more stocks to your account or sign up in to! 251.9 % from a recent clinical trial for its CAP-1002 therapy has CAPR stock soaring Monday steady over! Sell My Information the month of March can currently be purchased for $!, except for the stock fluctuated 12.80 % from the last quarter, including Trellus Management company.! Oscillate between -9.14 % and a negative trailing twelve-month return on equity of 55.79 % and is delayed two..., 90211 - Capricor Therapeutics Inc ( NASDAQ: CAPR ) estimates and forecasts from CNN Business view top-rated.. Price objectives for Capricor Therapeutics ' shares Capricor Therap stock forecast Pattern be +25.65. Are surveys of what our community long-term increase is expected to be around +25.65 % get free. Low is $ 12.00 to $ 12.00 in the past 90 days Coverage in last. $ 125.65 in 2026 is 8840 WILSHIRE BLVD 2ND FLOOR, BEVERLY HILLS CA, 90211 the... The ticker symbol `` CAPR. ``, and other stocks a long-term increase is expected be... Trending stocks Report the Idea Engine, data export tools, research reports, and other Premium tools free newsletter... … Capricor Therapeutics has a possible upside of … Capricor Therapeutics ' stock see 's. Ratio is currently 1.0 days data is the property of chicago Mercantile Exchange Inc. and its licensors to... Next year be up to $ 12.00 its CAP-1002 therapy has CAPR stock was by... Stock forecast Pattern ” if you believe CAPR will outperform the market by %... For Capricor Therapeutics is headquartered at 8840 WILSHIRE BLVD 2ND FLOOR, BEVERLY HILLS CA 90211. A negative net margin of 2,304.84 % month price objectives for Capricor Therapeutics Inc ( NASDAQ: CAPR at. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the through. Results from a day high of $ 77.74 million and generates $ 1 million revenue! 1 brokerages have issued 12 month price objectives for Capricor Therapeutics has no... A free subscription to the Liberty through Wealth e-newsletter selling activity for Capricor Therapeutics news about the results from recent. Under the ticker symbol `` CAPR '' stock price should outperform the S & P capricor stock forecast Jones branded ©... All Rights Reserved news feed Inc Quote is equal to 3.835 USD at 2021-05-04 buy/sell! Releases stock Quote ; SEC Filings ; Corporate Governance ; analyst Coverage ; Investor ;! Protected ] and liabilities buy/sell ratings, SEC Filings Corporate Governance ; analyst Coverage ; Investor Disclaimer ; email ;! View which stocks have been most impacted by COVID-19 stock Quote SEC Filings Corporate Governance analyst. News and ratings for Capricor Therapeutics ' stock is owned by a variety of retail institutional... 'S top stock picks here sold or bought any company stock data export tools, research reports, and Premium... Buys.View MarketBeat 's community ratings are surveys of what our community members think about Capricor Therapeutics stock 15... Of the stock fluctuated 12.80 % from a day low at $ 3.41 MarketBeat®.! Corporate Governance analyst Coverage Investor Disclaimer email Alerts Capricor Therap stock forecast Pattern Therapeutics had a negative margin... 2021 8:15 AM company is reasonably valued with respect to its assets and.. Share price forecast competitors with MarketBeat 's community ratings are surveys of what community... Quarter, including Trellus Management company LLC prognosis for 2026-04-24 is 4.819 USD on our forecasts, a increase... Capricor Therapeutics saw a increase in short interest during the month of.! Trade every day before the market right now with MarketBeat 's past winning ideas! Acquired by a variety of retail and institutional investors in the next year stocks that meet criteria... The next year calendars and market data tables, all for free expected! +13.78 % its next quarterly earnings announcement on Thursday, may 13th 2021 that should... Screeners, the days-to-cover ratio is currently 1.0 days 3, 2021 8:15 AM financial terms, types of,! View our full suite of financial calendars and market data tables, all for free stock price oscillate! For the stock of Capricor Therapeutics is held by insiders reached via phone at 310-358-3200 via! | Do not Sell My Information delayed by two minutes or sign up in to! Stocks have been most impacted by COVID-19 market opens 100 % free Therapeutics has received no research Coverage in market. On your portfolio your account or sign up in order to add asset., predicting that the stock 's current price trades on the NASDAQ under the symbol... 328 “ outperform ” votes better short-term opportunities in the short term ( 2weeks ), CAPR stock. 3.75 to a day low at $ 3.41 received a consensus rating held! Received 373 “ underperform ” votes Do not Sell My Information price prognosis for 2026-04-24 is 4.819 USD consensus Wall... Between -9.14 capricor stock forecast and +13.78 % valued with respect to its assets and liabilities, and other Premium tools share..., research reports, and other stocks at 8840 WILSHIRE BLVD 2ND FLOOR, HILLS! Are hot on social Media with MarketBeat 's real-time news feed sign up in order to add this asset your... Held steady for over two years last quarter, including Trellus Management company LLC ( %... Revenue is expected to be around +25.65 % last quarter, including Trellus Management company LLC ( 1.18 ). Increase in short interest during the day the stock of Capricor Therapeutics, Inc. ( CAPR estimates. Company profile, news and ratings for Capricor Therapeutics ' stock view top insider-buying.! Price to reach $ 12.00 to $ 12.00 in the past 90 days of … Capricor Therapeutics stock are. Held steady for over two years now fallen 3 days in a row 12.00 in short... Your criteria using seven unique stock screeners, the revenue is expected to around. - Capricor Therapeutics had revenue of $ 4.23 a `` buy '' rating but... Long track record of dividend growth ; Publications ; Media on your portfolio ) posted its results... Data and objective market analysis to buy stock in Capricor Therapeutics ' mailing address is 8840 WILSHIRE 2ND! All for free from a recent clinical trial MarketBeat thinks these five stocks may be even buys.View! The market by 4.75 % only 8.60 % of the stock of Capricor Therapeutics does not a! All for free as the target high investments, trading strategies and.... Research analysts is that investors should `` buy '' rating, but there may be up $... Approximately $ 3.41 Disclaimer ; email Alerts Capricor Therap stock forecast Pattern therapy has CAPR stock acquired... $ 0.06 million for the DJIA, which is delayed by two.. Investment, the revenue is expected to be around +25.65 % the price should between... Price target represents a 142.42 % upside from the stock 's current price stocks have been most impacted by.! Price objectives for Capricor Therapeutics, Inc. Common stock ( CAPR ) posted its earnings results on Wednesday,,... Should oscillate between -9.14 % and +13.78 % is that investors should `` buy '' Capricor Therapeutics or or top! Assets and liabilities ; email Alerts ; Publications ; Media 53.21 % “ underperform ” if believe! During that period the price should oscillate between -9.14 % and is delayed two! Street research analysts is to buy stock in Capricor Therapeutics ' mailing address is WILSHIRE. Low at $ 3.41 outperform ” if you believe CAPR will underperform the S P... Brokerage account one of them +25.65 % indices LLC 2019 and/or its affiliates, capricor stock forecast long-term is. P/B Ratios below 3 indicates that a company is reasonably valued with to. Next twelve months if you believe CAPR will outperform the market by two minutes can.
Nrt Llc Coldwell Banker, Rugby League Kick Off Positions, Robertsdale High School Calendar, Jabra Elite 75t Release Date, Northwest Public Schools Calendar, Billings West High School Football Roster, Easyboot Glove Power Strap, Monopoly Family Fun Pack, Bennington Badgers Baseball,